Pradaxa is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals Inc.. The primary component is Dabigatran Etexilate Mesylate.
| Product ID | 0597-0149_089eda8b-0f51-c567-37a7-6412754b1ff5 |
| NDC | 0597-0149 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Pradaxa |
| Generic Name | Dabigatran Etexilate Mesylate |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2011-08-08 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022512 |
| Labeler Name | Boehringer Ingelheim Pharmaceuticals Inc. |
| Substance Name | DABIGATRAN ETEXILATE MESYLATE |
| Active Ingredient Strength | 75 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2011-08-08 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022512 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-08-08 |
| Marketing End Date | 2019-09-30 |
| Marketing Category | NDA |
| Application Number | NDA022512 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-08-08 |
| Marketing End Date | 2019-09-30 |
| Marketing Category | NDA |
| Application Number | NDA022512 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2011-08-08 |
| Marketing End Date | 2019-08-31 |
| Ingredient | Strength |
|---|---|
| DABIGATRAN ETEXILATE MESYLATE | 75 mg/1 |
| SPL SET ID: | ba74e3cd-b06f-4145-b284-5fd6b84ff3c9 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0597-0108 | Pradaxa | dabigatran etexilate mesylate |
| 0597-0135 | Pradaxa | dabigatran etexilate mesylate |
| 0597-0149 | Pradaxa | dabigatran etexilate mesylate |
| 0597-0355 | Pradaxa | dabigatran etexilate mesylate |
| 0597-0360 | Pradaxa | dabigatran etexilate mesylate |
| 0597-0425 | Pradaxa | DABIGATRAN ETEXILATE MESYLATE |
| 0597-0430 | Pradaxa | DABIGATRAN ETEXILATE MESYLATE |
| 0597-0435 | Pradaxa | DABIGATRAN ETEXILATE MESYLATE |
| 0597-0440 | Pradaxa | DABIGATRAN ETEXILATE MESYLATE |
| 0597-0445 | Pradaxa | DABIGATRAN ETEXILATE MESYLATE |
| 0597-0450 | Pradaxa | DABIGATRAN ETEXILATE MESYLATE |
| 21695-899 | PRADAXA | dabigatran etexilate mesylate |
| 50090-3617 | Pradaxa | dabigatran etexilate mesylate |
| 50090-4480 | Pradaxa | dabigatran etexilate mesylate |
| 63629-8242 | Pradaxa | Pradaxa |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PRADAXA 85133694 3977066 Live/Registered |
Boehringer Ingelheim Pharma GmbH & Co.,KG 2010-09-20 |
![]() PRADAXA 79193638 5173798 Live/Registered |
Boehringer Ingelheim Pharma GmbH & Co KG 2016-04-06 |
![]() PRADAXA 79064548 3661185 Dead/Cancelled |
Boehringer Ingelheim Pharma GmbH & Co. KG 2008-10-29 |
![]() PRADAXA 78282869 2874805 Live/Registered |
Boehringer Ingelheim Pharma GmbH & Co. KG 2003-08-04 |